Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines

dc.contributor.authorCavestro, Giulia Martina
dc.contributor.authorMannucci, Alessandro
dc.contributor.authorBalaguer, Francesc
dc.contributor.authorHampel, Heather
dc.contributor.authorKupfer, Sonia S.
dc.contributor.authorRepici, Alessandro
dc.contributor.authorSartore-Bianchi, Andrea
dc.contributor.authorSeppälä, Toni T.
dc.contributor.authorValentini, Vincenzo
dc.contributor.authorBoland, Clement Richard
dc.contributor.authorBrand, Randall E.
dc.contributor.authorBuffart, Tineke E.
dc.contributor.authorBurke, Carol A.
dc.contributor.authorCaccialanza, Riccardo
dc.contributor.authorCannizzaro, Renato
dc.contributor.authorCascinu, Stefano
dc.contributor.authorCercek, Andrea
dc.contributor.authorCrosbie, Emma J.
dc.contributor.authorDanese, Silvio
dc.contributor.authorDekker, Evelien
dc.contributor.authorDaca-Alvarez, Maria
dc.contributor.authorDeni, Francesco
dc.contributor.authorDominguez-Valentin, Mev
dc.contributor.authorEng, Cathy
dc.contributor.authorGoel, Ajay
dc.contributor.authorGuillem, Josè G.
dc.contributor.authorHouwen, Britt B. S. L.
dc.contributor.authorKahi, Charles
dc.contributor.authorKalady, Matthew F.
dc.contributor.authorKastrinos, Fay
dc.contributor.authorKühn, Florian
dc.contributor.authorLaghi, Luigi
dc.contributor.authorLatchford, Andrew
dc.contributor.authorLiska, David
dc.contributor.authorLynch, Patrick
dc.contributor.authorMalesci, Alberto
dc.contributor.authorMauri, Gianluca
dc.contributor.authorMeldolesi, Elisa
dc.contributor.authorMøller, Pål
dc.contributor.authorMonahan, Kevin J.
dc.contributor.authorMöslein, Gabriela
dc.contributor.authorMurphy, Caitlin C.
dc.contributor.authorNass, Karlijn
dc.contributor.authorNg, Kimmie
dc.contributor.authorOliani, Cristina
dc.contributor.authorPapaleo, Enrico
dc.contributor.authorPatel, Swati G.
dc.contributor.authorPuzzono, Marta
dc.contributor.authorRemo, Andrea
dc.contributor.authorRicciardiello, Luigi
dc.contributor.authorRipamonti, Carla Ida
dc.contributor.authorSiena, Salvatore
dc.contributor.authorSingh, Satish K.
dc.contributor.authorStadler, Zsofia K.
dc.contributor.authorStanich, Peter P.
dc.contributor.authorSyngal, Sapna
dc.contributor.authorTuri, Stefano
dc.contributor.authorUrso, Emanuele Damiano
dc.contributor.authorValle, Laura
dc.contributor.authorVanni, Valeria Stella
dc.contributor.authorVilar, Eduardo
dc.contributor.authorVitellaro, Marco
dc.contributor.authorYou, Yi-Qian Nancy
dc.contributor.authorYurgelun, Matthew B.
dc.contributor.authorZuppardo, Raffaella Alessia
dc.contributor.authorStoffel, Elena M.
dc.contributor.authorAssociazione Italiana Familiarità Ereditarietà Tumori
dc.contributor.authorCollaborative Group of the Americas on Inherited Gastrointestinal Cancer
dc.contributor.authorEuropean Hereditary Tumour Group
dc.contributor.authorInternational Society for Gastrointestinal Hereditary Tumours
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2024-09-05T15:12:12Z
dc.date.available2024-09-05T15:12:12Z
dc.date.issued2023
dc.description.abstractBackground & aims: Patients with early-onset colorectal cancer (eoCRC) are managed according to guidelines that are not age-specific. A multidisciplinary international group (DIRECt), composed of 69 experts, was convened to develop the first evidence-based consensus recommendations for eoCRC. Methods: After reviewing the published literature, a Delphi methodology was used to draft and respond to clinically relevant questions. Each statement underwent 3 rounds of voting and reached a consensus level of agreement of ≥80%. Results: The DIRECt group produced 31 statements in 7 areas of interest: diagnosis, risk factors, genetics, pathology-oncology, endoscopy, therapy, and supportive care. There was strong consensus that all individuals younger than 50 should undergo CRC risk stratification and prompt symptom assessment. All newly diagnosed eoCRC patients should receive germline genetic testing, ideally before surgery. On the basis of current evidence, endoscopic, surgical, and oncologic treatment of eoCRC should not differ from later-onset CRC, except for individuals with pathogenic or likely pathogenic germline variants. The evidence on chemotherapy is not sufficient to recommend changes to established therapeutic protocols. Fertility preservation and sexual health are important to address in eoCRC survivors. The DIRECt group highlighted areas with knowledge gaps that should be prioritized in future research efforts, including age at first screening for the general population, use of fecal immunochemical tests, chemotherapy, endoscopic therapy, and post-treatment surveillance for eoCRC patients. Conclusions: The DIRECt group produced the first consensus recommendations on eoCRC. All statements should be considered together with the accompanying comments and literature reviews. We highlighted areas where research should be prioritized. These guidelines represent a useful tool for clinicians caring for patients with eoCRC.
dc.eprint.versionAuthor's manuscript
dc.identifier.citationCavestro GM, Mannucci A, Balaguer F, et al. Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines. Clin Gastroenterol Hepatol. 2023;21(3):581-603.e33. doi:10.1016/j.cgh.2022.12.006
dc.identifier.urihttps://hdl.handle.net/1805/43164
dc.language.isoen_US
dc.publisherElsevier
dc.relation.isversionof10.1016/j.cgh.2022.12.006
dc.relation.journalClinical Gastroenterology and Hepatology
dc.rightsPublisher Policy
dc.sourcePMC
dc.subject50 years
dc.subjectClinical
dc.subjectColorectal cancer
dc.subjectRecommendation
dc.subjectYoung
dc.titleDelphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Cavestro2023Delphi-AAM.pdf
Size:
536.91 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: